AT-Patch (ATP-C130/ATP-C70) vs cV5 Diagnostic Ultrasound System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AT-Patch (ATP-C130/ATP-C70)

by ATsens Co.

cV5 Diagnostic Ultrasound System

by Samsung Medison

AI Verdict

Tool A is an ambulatory ECG monitor designed for continuous cardiac monitoring and AI-powered arrhythmia detection. Tool B is a versatile diagnostic ultrasound system that uses AI to enhance imaging and streamline workflows across multiple specialties, including cardiology. While both leverage AI in cardiology, they employ distinct diagnostic modalities (ECG vs. ultrasound imaging) and serve complementary purposes in cardiac assessment, making them adjacent rather than direct competitors.

Choose AT-Patch (ATP-C130/ATP-C70) if…

Choose AT-Patch if you require extended, continuous cardiac monitoring for up to 14 days to detect intermittent arrhythmias, prioritizing patient comfort and convenience with a lightweight, shower-proof wearable device. This tool is ideal for ambulatory patients needing long-term ECG data collection without the need for charging or electrode replacement during the monitoring period.

View AT-Patch (ATP-C130/ATP-C70) →

Choose cV5 Diagnostic Ultrasound System if…

Choose the Samsung cV5 Diagnostic Ultrasound System if your practice requires versatile, high-resolution real-time imaging across multiple specialties like cardiology, OB/GYN, or radiology. This system is best suited for clinicians needing advanced AI-assisted tools for confident diagnostic decision-making, detailed anatomical visualization, and comprehensive functional assessments.

View cV5 Diagnostic Ultrasound System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AT-Patch (ATP-C130/ATP-C70)	cV5 Diagnostic Ultrasound System
Deployment	Wearable device for patients; analysis software deployed on-premise at medical institutions.	On-premise (ultrasound system)
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AT-Patch (ATP-C130/ATP-C70)

AT-Patch excels in patient usability with its compact, lightweight (13g), and shower-proof design, allowing up to 14 days of continuous monitoring without charging or electrode replacement. The accompanying AT-Note smartphone app further enhances patient convenience for live ECG viewing and symptom recording. While the cV5 offers strong clinician usability with ergonomic design and intuitive interfaces, AT-Patch's patient-centric features are a significant advantage for a wearable device.

Clinical Value

cV5 Diagnostic Ultrasound System

The cV5 Diagnostic Ultrasound System provides high-quality imaging and a broad suite of AI-powered tools like HeartAssistu2122 and BiometryAssistu2122 for confident decision-making across multiple specialties including Cardiology, OB/GYN, and Radiology. Its versatile applications and comprehensive AI features offer a wider range of diagnostic capabilities compared to AT-Patch's specialized focus on long-term ECG monitoring and arrhythmia detection, despite AT-Patch's proven accuracy in its domain.

Pricing & Value

Tie

Neither tool provides publicly available pricing information, with both requiring direct contact with the vendor for details. Without any transparent pricing, it is impossible to conduct a meaningful comparison of their respective value propositions.

Enterprise Readiness

cV5 Diagnostic Ultrasound System

The cV5 Diagnostic Ultrasound System explicitly details its HIPAA compliance, robust data export capabilities including DICOM and HL7 formats, and a Cybersecurity Suite with DICOM TLS for secure data handling. These features demonstrate a strong readiness for integration into complex healthcare IT environments. While AT-Patch is likely HIPAA compliant, it lacks explicit mention of such comprehensive integration and security features.

Innovation

cV5 Diagnostic Ultrasound System

Both tools showcase innovation, with AT-Patch offering a patient-friendly, long-term ECG monitor with AI-powered arrhythmia detection. However, the cV5 Diagnostic Ultrasound System integrates a broader and deeper array of AI and productivity tools, such as Crystal Architectureu2122 for enhanced imaging and numerous AI-assisted measurement tools (e.g., HeartAssistu2122, AutoEF, ArterialAnalysisu2122) across diverse specialties. This comprehensive AI integration for diagnostic workflows represents a wider scope of innovation.

Support & Docs

cV5 Diagnostic Ultrasound System

Both companies provide user manuals and customer service contact information. However, Samsung Medison explicitly states that they will make available circuit diagrams, component parts lists, and calibration instructions upon request to qualified technical personnel for repairs. This level of detailed technical support for maintenance and repair gives Tool B an edge in comprehensive documentation and support.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AT-Patch (ATP-C130/ATP-C70)	cV5 Diagnostic Ultrasound System
Product Name	AT-Patch (ATP-C130/ATP-C70)	cV5 Diagnostic Ultrasound System
Company	ATsens Co.	Samsung Medison Co.
Device Type / Primary Function	Wearable ECG monitor for continuous cardiac monitoring	AI-assisted diagnostic ultrasound solution
Key AI Capabilities	AI/machine learning algorithms for ECG analysis (within AT-Report software)	HeartAssistu2122, AutoEF, Strain+, TMAD, AutoIMT+, ArterialAnalysisu2122, BiometryAssistu2122
Monitoring/Imaging Specifics	Up to 14 days of continuous ECG monitoring (ATP-C130)	Crystal Architectureu2122 with ClearVision, S-Harmonicu2122, HQ-Visionu2122, ShadowHDRu2122, MultiVision for enhanced image quality; Broad compatibility with S-Vueu2122 transducers (1u201322 MHz); Multiple imaging modes (2D, M-Mode, Color/Power Doppler, etc.)
Physical Design / Form Factor	Compact and lightweight (13g), shower-proof design (IP57 for ATP-C130, IP44 for ATP-C70), short-length electrode.	21.5u201d or 23.8u201d Full HD LED monitor with IPS technology and 14u201d tilting touchscreen.
Data Handling / Storage	AT-Note smartphone app for live ECG viewing and symptom recording.	512GB SSD + 1TB expanded storage; Data export capabilities including AVI, MPEG, JPEG, TIFF, BMP, and DICOM formats; Cybersecurity Suite with DICOM TLS and HL7 integration.

Videos

Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and cV5 Diagnostic Ultrasound System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools fit into existing clinical workflows for patient data acquisition and analysis?

The AT-Patch is a wearable ECG monitor that patients use for up to 14 days, with data viewable via the AT-Note smartphone app and analyzed by AT-Report software with AI/ML algorithms. The Samsung cV5 is a diagnostic ultrasound system that offers real-time imaging with AI & Productivity Tools like HeartAssistu2122 and QuickScanu2122 to streamline measurements and workflows, and it can export data in various formats including DICOM.

What are the capabilities for integrating patient data and reports from these tools into our existing Electronic Health Record (EHR) system?

The AT-Patch's analysis software is deployed on-premise, suggesting potential for integration, though specific EHR integration methods are not detailed. The Samsung cV5 explicitly features DICOM TLS and HL7 integration, which are key standards for exchanging medical images and clinical data with EHR systems.

How do the design and AI features of each tool contribute to the accuracy and reliability of diagnostic information?

The AT-Patch utilizes a high-performance sensor chip and short-length electrodes to minimize motion artifact noise for accurate ECG signal acquisition, complemented by AI/machine learning algorithms for enhanced arrhythmia detection. The Samsung cV5 employs Crystal Architectureu2122 with technologies like ClearVision and HQ-Visionu2122 for enhanced image quality, and AI tools such as HeartAssistu2122 and AutoEF to refine accuracy and provide real-time clinical insights.

What is the expected learning curve for physicians and staff to become proficient with each system, and how do the integrated AI features assist in this?

The AT-Patch, as a wearable, is designed for patient comfort and ease of use, while its AT-Report software includes AI for ECG analysis, potentially streamlining the interpretation process for staff. The Samsung cV5, a comprehensive ultrasound system, incorporates AI & Productivity Tools like EzExam+u2122 and QuickScanu2122 to simplify daily operations and automate measurements, which can help reduce the learning curve for specific tasks and enhance daily efficiency.

What specific security measures, beyond standard compliance, are implemented to protect patient data and system integrity?

The AT-Patch does not explicitly detail security measures beyond general operation within the US healthcare system for patient data. The Samsung cV5 includes a Cybersecurity Suite with DICOM TLS and HL7 integration, which provides secure data handling during transmission and exchange with other systems.

What audit-trail functionalities are available to track user actions and data modifications within each system?

The AT-Patch's description does not explicitly mention audit-trail features. The Samsung cV5's Cybersecurity Suite, which includes DICOM TLS and HL7 integration, often implies underlying audit trail capabilities for tracking data exchange and system activity, as DICOM and HL7 integrations typically support logging for compliance and security.

What are the key considerations for deploying these tools across multiple clinical sites or a larger healthcare system?

For the AT-Patch, multi-site deployment would involve distributing the wearable devices to patients and managing the on-premise analysis software across different medical institutions. The Samsung cV5, being on-premise hardware with DICOM and HL7 integration, would require considerations for physical installation, network integration, and consistent data exchange protocols across multiple sites.